265 related articles for article (PubMed ID: 25703326)
1. Regulatory circuit of PKM2/NF-κB/miR-148a/152-modulated tumor angiogenesis and cancer progression.
Xu Q; Liu LZ; Yin Y; He J; Li Q; Qian X; You Y; Lu Z; Peiper SC; Shu Y; Jiang BH
Oncogene; 2015 Oct; 34(43):5482-93. PubMed ID: 25703326
[TBL] [Abstract][Full Text] [Related]
2. A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.
Xu Q; Jiang Y; Yin Y; Li Q; He J; Jing Y; Qi YT; Xu Q; Li W; Lu B; Peiper SS; Jiang BH; Liu LZ
J Mol Cell Biol; 2013 Feb; 5(1):3-13. PubMed ID: 22935141
[TBL] [Abstract][Full Text] [Related]
3. PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation.
Azoitei N; Becher A; Steinestel K; Rouhi A; Diepold K; Genze F; Simmet T; Seufferlein T
Mol Cancer; 2016 Jan; 15():3. PubMed ID: 26739387
[TBL] [Abstract][Full Text] [Related]
4. Lactate secreted by PKM2 upregulation promotes Galectin-9-mediated immunosuppression via inhibiting NF-κB pathway in HNSCC.
Chang H; Xu Q; Li J; Li M; Zhang Z; Ma H; Yang X
Cell Death Dis; 2021 Jul; 12(8):725. PubMed ID: 34290225
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of miR-338 facilitates glioblastoma progression by de-repressing the pyruvate kinase M2-β-catenin axis.
Han B; Meng X; Chen H; Chen L; Liu X; Wang H; Liu D; Gao F; Lin L; Ming J; Sun B; Yin S; Wang R; Wu P; Cai J; Jiang C
Aging (Albany NY); 2017 Aug; 9(8):1885-1897. PubMed ID: 28858851
[TBL] [Abstract][Full Text] [Related]
6. NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma.
Wang H; Pan JQ; Luo L; Ning XJ; Ye ZP; Yu Z; Li WS
Mol Cancer; 2015 Feb; 14():2. PubMed ID: 25971746
[TBL] [Abstract][Full Text] [Related]
7. EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.
Yang W; Xia Y; Cao Y; Zheng Y; Bu W; Zhang L; You MJ; Koh MY; Cote G; Aldape K; Li Y; Verma IM; Chiao PJ; Lu Z
Mol Cell; 2012 Dec; 48(5):771-84. PubMed ID: 23123196
[TBL] [Abstract][Full Text] [Related]
8. IGF-1-mediated PKM2/β-catenin/miR-152 regulatory circuit in breast cancer.
Wen YY; Liu WT; Sun HR; Ge X; Shi ZM; Wang M; Li W; Zhang JY; Liu LZ; Jiang BH
Sci Rep; 2017 Nov; 7(1):15897. PubMed ID: 29162853
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
[TBL] [Abstract][Full Text] [Related]
10. MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma.
Chen J; Yu Y; Chen X; He Y; Hu Q; Li H; Han Q; Ren F; Li J; Li C; Bao J; Ren Z; Duan Z; Cui G; Sun R
Cell Prolif; 2018 Dec; 51(6):e12510. PubMed ID: 30105813
[TBL] [Abstract][Full Text] [Related]
11. miR-361-5p modulates metabolism and autophagy via the Sp1-mediated regulation of PKM2 in prostate cancer.
Ling Z; Liu D; Zhang G; Liang Q; Xiang P; Xu Y; Han C; Tao T
Oncol Rep; 2017 Sep; 38(3):1621-1628. PubMed ID: 29094170
[TBL] [Abstract][Full Text] [Related]
12. miR-625-5p/PKM2 negatively regulates melanoma glycolysis state.
Zhang H; Feng C; Zhang M; Zeng A; Si L; Yu N; Bai M
J Cell Biochem; 2019 Mar; 120(3):2964-2972. PubMed ID: 30500994
[TBL] [Abstract][Full Text] [Related]
13. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer.
Guo M; Zhao X; Yuan X; Jiang J; Li P
Oncotarget; 2017 Apr; 8(17):28226-28236. PubMed ID: 28415668
[TBL] [Abstract][Full Text] [Related]
14. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.
Yao A; Xiang Y; Si YR; Fan LJ; Li JP; Li H; Guo W; He HX; Liang XJ; Tan Y; Bao LY; Liao XH
J Cell Biochem; 2019 Apr; 120(4):6542-6554. PubMed ID: 30368881
[TBL] [Abstract][Full Text] [Related]
15. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer.
Tang R; Yang C; Ma X; Wang Y; Luo D; Huang C; Xu Z; Liu P; Yang L
Oncotarget; 2016 Feb; 7(5):5972-84. PubMed ID: 26745603
[TBL] [Abstract][Full Text] [Related]
16. PKM2 and HIF-1α regulation in prostate cancer cell lines.
Hasan D; Gamen E; Abu Tarboush N; Ismail Y; Pak O; Azab B
PLoS One; 2018; 13(9):e0203745. PubMed ID: 30216369
[TBL] [Abstract][Full Text] [Related]
17. A negative feedback loop between miR-200b and the nuclear factor-κB pathway via IKBKB/IKK-β in breast cancer cells.
Wu H; Wang G; Wang Z; An S; Ye P; Luo S
FEBS J; 2016 Jun; 283(12):2259-71. PubMed ID: 26433127
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis.
Long XR; He Y; Huang C; Li J
Int J Oncol; 2014 Jun; 44(6):1915-22. PubMed ID: 24714841
[TBL] [Abstract][Full Text] [Related]
19. miR-4417 Targets Tripartite Motif-Containing 35 (TRIM35) and Regulates Pyruvate Kinase Muscle 2 (PKM2) Phosphorylation to Promote Proliferation and Suppress Apoptosis in Hepatocellular Carcinoma Cells.
Song L; Zhang W; Chang Z; Pan Y; Zong H; Fan Q; Wang L
Med Sci Monit; 2017 Apr; 23():1741-1750. PubMed ID: 28394882
[TBL] [Abstract][Full Text] [Related]
20. MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.
Xu X; Zhang Y; Jasper J; Lykken E; Alexander PB; Markowitz GJ; McDonnell DP; Li QJ; Wang XF
Oncotarget; 2016 Apr; 7(15):20381-94. PubMed ID: 26967387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
